California Healthcare Institute Launches Innovative Web Site for California's Life Sciences Industry.LA JOLLA, Calif. -- www.chi.org provides instant information access to California life sciences technologies, innovation, people, and state and federal public policies affecting medical innovation The California Healthcare Institute (CHI) launched www.chi.org, the most comprehensive Internet resource for information about California's life sciences industry - the companies, academic research, people, events, along with insight into state and federal policies and legislation that affect medical innovation. "California is the global leader in biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. R&D. CHI and its member companies and institutions believe that cooperative efforts among commercial firms, academic research entities and government are critical to advancing medical innovation and fostering scientific discovery," said David L. Gollaher, Ph.D., CHI president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "One clearinghouse location on the Internet is the ideal platform to foster cooperation through state-of-the-art technology tools, trend-setting ideas and information that will enhance and improve the life sciences in California." The new Web site brings together the innovators and leaders of California's life sciences industry through the Internet to educate and build awareness of how the industry is contributing to California's economic future and transforming health around the world. Highlights of information featured on the site includes: --More than 100 research programs at biotechnology pioneer Amgen to develop new treatments for grievous illnesses --The Berkeley Biotechnology Education Institute (BBEI BBEI Bau-Biology Environmental Inspector ), an award winning biotechnology workforce development program resulting from a model public-private partnership between Bayer Healthcare (NYSE NYSE See: New York Stock Exchange :BAY) and the City of Berkeley --Edwards Lifesciences (NYSE:EW) recent breakthroughs in less-invasive devices and technologies to treat advanced cardiovascular disease --"Faces of Science" showcasing researchers at California's leading biomedical companies including Genentech (NYSE:DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. ) scientists advancing recombinant protein therapies to address unmet medical needs --The first once-daily single tablet regimen to treat HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. developed by Gilead Sciences (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :GILD) and Bristol Myers-Squibb (NYSE:BMY BMY Bristol Myers Squibb ) --The Los Angeles Biomedical Research Institute's clinical trials for pharmaceuticals, biologics and medical devices www.chi.org also features CHI's information, position statements and action on state and federal legislation, regulations and policies affecting medical innovation in the state, including: --A recent white paper outlining strategies for prevention and response to avian flu and other public health catastrophes --CHI's recent comments to the California Institute for Regenerative Medicine's proposed intellectual property policy for non-profit organizations --CHI's recent comments to the U.S. Centers for Medicare and Medicaid Services The Centers for Medicare and Medicaid Services (CMS), previously known as the Health Care Financing Administration (HCFA), is a federal agency within the United States Department of Health and Human Services (DHHS) that administers the Medicare program and (CMS (1) See content management system and color management system. (2) (Conversational Monitor System) Software that provides interactive communications for IBM's VM operating system. ) seeking revisions to a proposal that could limit access and quality of care for Medicare beneficiaries suffering from diabetes Industry, technology, business leaders and policymakers will celebrate the launch of www.chi.org at an interactive reception showcasing discovery, innovation and progress in California's vibrant life sciences enterprise. The launch of the new, innovative Web site is supported by Mintz Levin Cohn Ferris Glovsky & Popeo PC, Amgen, Bayer HealthCare, Edwards Lifesciences, Genentech, Gilead Sciences, Los Angeles Biomedical Research Institute, Enterprise Partners Venture Capital, NASDAQ and PINT. CHI represents more than 250 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI's mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion